These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23826822)

  • 1. Granulomatous disease in a child treated with etanercept.
    Alhajri M; Aljumaah S; Aleyouni Y; Al-Qahtani F; Alhazzaa S; Al-Mayouf SM
    Int J Rheum Dis; 2013 Aug; 16(4):472-4. PubMed ID: 23826822
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis.
    Livermore PA; Murray KJ
    Rheumatology (Oxford); 2002 Dec; 41(12):1450-2. PubMed ID: 12468829
    [No Abstract]   [Full Text] [Related]  

  • 3. Crohn's disease in a patient with juvenile idiopathic arthritis after starting etanercept therapy - causal link or only temporal coincidence?
    Flemming GM; Tóth G; Gebauer C; Schuster V
    Klin Padiatr; 2013 Nov; 225(6):350-1. PubMed ID: 24166091
    [No Abstract]   [Full Text] [Related]  

  • 4. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
    van der Stoep D; Braunstahl GJ; van Zeben J; Wouters J
    J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis.
    Lepore L; Marchetti F; Facchini S; Leone V; Ventura A
    Clin Exp Rheumatol; 2003; 21(2):276-7. PubMed ID: 12747299
    [No Abstract]   [Full Text] [Related]  

  • 6. Adalimumab in juvenile rheumatoid arthritis.
    Taddio A; Marchetti F
    N Engl J Med; 2008 Dec; 359(23):2495-6; author reply 2496-7. PubMed ID: 19065749
    [No Abstract]   [Full Text] [Related]  

  • 7. [Swiss registry for TNF-alpha blockers in children and adolescents with rheumatological diseases].
    Sauvain MJ; Schalm SB; Bérthet G; Bolz D; Cannizzaro E; Hofer M; Kaiser D; Saurenmann RK; Bolt IB
    Praxis (Bern 1994); 2010 May; 99(11):649-54. PubMed ID: 20506089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept in methotrexate-resistant JIA-related uveitis.
    Saeed MU; Raza SH; Goyal S; Cleary G; Newman WD; Chandna A
    Semin Ophthalmol; 2014 Jan; 29(1):1-3. PubMed ID: 24175644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy.
    Vigne C; Tebib JG; Pacheco Y; Coury F
    Joint Bone Spine; 2013 Jan; 80(1):104-7. PubMed ID: 22885144
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of sarcoidosis during etanercept therapy.
    González-López MA; Blanco R; González-Vela MC; Fernández-Llaca H; Rodríguez-Valverde V
    Arthritis Rheum; 2006 Oct; 55(5):817-20. PubMed ID: 17013853
    [No Abstract]   [Full Text] [Related]  

  • 11. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
    Lai JH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
    [No Abstract]   [Full Text] [Related]  

  • 12. Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases.
    Toussirot E; Pertuiset E; Kantelip B; Wendling D
    Clin Exp Rheumatol; 2008; 26(3):471-5. PubMed ID: 18578973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset psoriasis associated with etanercept therapy.
    Chen LA; Su LH; Chang YJ; Hsu YL; Tsai TH
    J Dermatol; 2010 Apr; 37(4):378-80. PubMed ID: 20507411
    [No Abstract]   [Full Text] [Related]  

  • 14. Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis.
    Liu SW; Velez NF; Lam C; Femia A; Granter SR; Townsend HB; Vleugels RA
    JAMA Dermatol; 2013 Oct; 149(10):1204-8. PubMed ID: 23986394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept-associated right abducens nerve palsy in rheumatoid arthritis.
    Lai CC; Hsiao KH; Chang YS; Tsai CY; Chou CT
    Int J Rheum Dis; 2012 Oct; 15(5):e117-9. PubMed ID: 23083045
    [No Abstract]   [Full Text] [Related]  

  • 16. Etanercept allergy and anaphylaxis.
    Quismorio A; Brahmbhatt B; Houng M; Panush RS
    J Rheumatol; 2012 Nov; 39(11):2225-6. PubMed ID: 23118296
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
    Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
    Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of sarcoidosis following etanercept treatment: a report of three cases.
    Skoie IM; Wildhagen K; Omdal R
    Rheumatol Int; 2012 Apr; 32(4):1049-53. PubMed ID: 20062997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis.
    Giannini EH; Ilowite NT; Lovell DJ; Wallace CA; Rabinovich CE; Reiff A; Higgins G; Gottlieb B; Chon Y; Zhang N; Baumgartner SW
    Arthritis Rheum; 2010 Nov; 62(11):3259-64. PubMed ID: 20669280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortitis during etanercept therapy for ankylosing spondylitis: finding the culprit.
    Verhoeven F; Bossert M; Lohse-Walliser A; Balblanc JC
    Joint Bone Spine; 2012 Oct; 79(5):524-6. PubMed ID: 22575065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.